OrganoClick AB (0CF) Stock Statistics & Valuation Metrics
Total Valuation
OrganoClick AB has a market cap or net worth of EUR 7.62M. The enterprise value is EUR 130.45M.
- Market Cap
- EUR 7.62M
- Enterprise Value
- EUR 130.45M
Share Statistics
OrganoClick AB has 183,219,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 183,219,120
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
OrganoClick AB’s return on equity (ROE) is -2.40 and return on invested capital (ROIC) is -31.36%.
- Return on Equity (ROE)
- -2.40
- Return on Assets (ROA)
- -0.27
- Return on Invested Capital (ROIC)
- -31.36%
- Return on Capital Employed (ROCE)
- -0.71
- Revenue Per Employee
- 3.22M
- Profits Per Employee
- -1.10M
- Employee Count
- 33
- Asset Turnover
- 0.79
- Inventory Turnover
- 3.87
Valuation Ratios
The current PE Ratio of OrganoClick AB is -1.52. OrganoClick AB’s PEG ratio is 0.05.
- PE Ratio
- -1.52
- PS Ratio
- 0.93
- PB Ratio
- 4.78
- Price to FCF
- -11.42
- Price to Operating Cash Flow
- -12.50
- PEG Ratio
- 0.05
Income Statement
In the last 12 months, OrganoClick AB had revenue of 106.19M and earned -36.37M in profits. Earnings per share was -0.36.
- Revenue
- 106.19M
- Gross Profit
- 14.86M
- Operating Income
- -31.51M
- Pretax Income
- -38.29M
- Net Income
- -36.37M
- EBITDA
- -12.80M
- Earnings Per Share (EPS)
- -0.36
Cash Flow
In the last 12 months, operating cash flow was -4.03M and capital expenditures -3.31M, giving a free cash flow of -7.35M billion.
- Operating Cash Flow
- -4.03M
- Free Cash Flow
- -7.35M
- Free Cash Flow per Share
- -0.07
Dividends & Yields
OrganoClick AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.75%
- Earnings Yield
- -63.89%
Stock Price Statistics
- Beta
- 3.20
- 52-Week Price Change
- -69.90%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.06
- Relative Strength Index (RSI)
- 58.47
- Average Volume (3m)
- 1,364
Important Dates
OrganoClick AB upcoming earnings date is Nov 05, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 12, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
OrganoClick AB as a current ratio of 0.45, with Debt / Equity ratio of 512.47%
- Current Ratio
- 0.45
- Quick Ratio
- 0.19
- Debt to Market Cap
- 0.28
- Net Debt to EBITDA
- -5.87
- Interest Coverage Ratio
- -4.66
Taxes
In the past 12 months, OrganoClick AB has paid -293.00K in taxes.
- Income Tax
- -293.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
OrganoClick AB EV to EBITDA ratio is -17.48, with an EV/FCF ratio of -22.05.
- EV to Sales
- 1.79
- EV to EBITDA
- -17.48
- EV to Free Cash Flow
- -22.05
- EV to Operating Cash Flow
- -40.18
Balance Sheet
OrganoClick AB has EUR 480.00K in cash and marketable securities with EUR 78.56M in debt, giving a net cash position of -EUR 78.08M billion.
- Cash & Marketable Securities
- EUR 480.00K
- Total Debt
- EUR 78.56M
- Net Cash
- -EUR 78.08M
- Net Cash Per Share
- -EUR 0.43
- Tangible Book Value Per Share
- -EUR 0.32
Margins
Gross margin is 15.63%, with operating margin of -29.68%, and net profit margin of -35.66%.
- Gross Margin
- 15.63%
- Operating Margin
- -29.68%
- Pretax Margin
- -37.34%
- Net Profit Margin
- -35.66%
- EBITDA Margin
- -10.26%
- EBIT Margin
- -29.68%
Analyst Forecast
The average price target for OrganoClick AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -19.35%
- EPS Growth Forecast
- -32.04%